Cargando…
Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
BACKGROUND AND OBJECTIVE: Lung cancer remains the leading cause of cancer-related mortality and constitutes a significant societal burden. Recent advancements in targeted therapies and immunotherapy have considerably broadened therapeutic options in lung cancer, particularly in non-small-cell lung c...
Autores principales: | Tomasik, Bartłomiej, Skrzypski, Marcin, Bieńkowski, Michał, Dziadziuszko, Rafał, Jassem, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087994/ https://www.ncbi.nlm.nih.gov/pubmed/37057121 http://dx.doi.org/10.21037/tlcr-22-742 |
Ejemplares similares
-
Complex EGFR mutations in non-small cell lung cancer: a distinct entity?
por: Bieńkowski, Michał, et al.
Publicado: (2022) -
Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
por: Łazar-Poniatowska, Małgorzata, et al.
Publicado: (2021) -
Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents
por: Wrona, Anna, et al.
Publicado: (2021) -
Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review
por: Smolle, Elisabeth, et al.
Publicado: (2021) -
Osimertinib – effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors
por: Skrzypski, Marcin, et al.
Publicado: (2017)